Understanding how RNA processing works in a parasite that affects public health in Africa

Mitochondrial RNA Uridylation in Trypanosomes

NIH-funded research Boston University Medical Campus · NIH-11041043

This study is looking at how a parasite called Trypanosoma brucei, which causes health problems in Africa, processes its RNA to help it survive and avoid our immune system, and it could help us learn more about how similar cells work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11041043 on NIH RePORTER

What this research studies

This research investigates the mechanisms of RNA maturation and editing in the Trypanosoma brucei parasite, which causes significant health issues in Sub-Saharan Africa. By focusing on the role of specific enzymes involved in RNA processing, the study aims to uncover how these processes affect the parasite's biology and its ability to evade the immune system. The research employs advanced techniques such as molecular biology, proteomics, imaging, and cryo-electron microscopy to analyze the interactions and functions of RNA-related protein complexes. This work could provide insights into fundamental biological processes that may have broader implications for understanding eukaryotic cells.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in Sub-Saharan Africa who are affected by Trypanosoma brucei infections.

Not a fit: Patients with infections caused by other pathogens or those outside the geographic focus of Sub-Saharan Africa may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for combating parasitic infections that significantly impact public health.

How similar studies have performed: Previous research has shown success in understanding RNA processing in other organisms, suggesting that this approach could yield valuable insights, although the specific focus on Trypanosoma brucei is relatively novel.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.